Managed care stocks came under pressure after Pfizer CEO Albert Bourla said U.S. President-elect Donald Trump is “very committed” to reforming the pharmacy benefit manager industry, with Humana (HUM) ...

"Through this agreement, we aim to build on our experience targeting incretin biology to evaluate HS-10535 and its potential to provide additional cardiometabolic benefits beyond weight reduction ...